Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clofem Plus is a fixed-dose combination medication containing aceclofenac and paracetamol, manufactured by Modi Lifecare Industries. It is categorized as an analgesic, antipyretic, and non-steroidal anti-inflammatory drug (NSAID). Aceclofenac works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the synthesis of prostaglandins that mediate pain and inflammation. Paracetamol provides additional analgesic and antipyretic effects, primarily through central nervous system mechanisms. The combination is used to manage pain and inflammation in conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aceclofenac + paracetamol (Modi Lifecare Industries).